Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of eye disorders
3.2.1.2 Growth in active screen time
3.2.1.3 Advancements in product delivery technologies
3.2.1.4 Rising geriatric population
3.2.2 Industry pitfalls & challenges
3.2.2.1 High costs associated with advanced supplements
3.2.2.2 Potential side effects
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.5.1 Core technologies
3.5.2 Adjacent technologies
3.6 Pricing analysis, 2023
3.6.1 By region
3.6.2 By key player
3.7 Future market trends
3.8 Pipeline analysis
3.9 Porter’s analysis
3.10 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Ingredient Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Lutein and zeaxanthin
5.3 Antioxidants
5.4 Omega-3 fatty acids
5.5 Coenzyme Q10
5.6 Flavonoids
5.7 Alpha-lipoic acid
5.8 Astaxanthin
5.9 Other ingredient types
Chapter 6 Market Estimates and Forecast, By Indication, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Age-related macular degeneration (AMD)
6.3 Cataract
6.4 Glaucoma
6.5 Eye fatigue
6.6 Corneal support
6.7 Eyelid conjunctivitis
6.8 Other indications
Chapter 7 Market Estimates and Forecast, By Formulations, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Tablet/capsule
7.3 Liquid
7.4 Gels
7.5 Gummies
7.6 Powder
Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospital pharmacy
8.3 Retail pharmacy
8.4 Online pharmacy
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Alcon Inc.
10.2 Alliance Pharma plc
10.3 Bausch Health Companies Inc.
10.4 Bluebonnet Nutrition
10.5 Basic Brands Inc.
10.6 Herbalife Ltd.
10.7 Healthy Origins USA
10.8 NusaPure
10.9 Nordic Naturals
10.10 Nestlé S.A.
10.11 Nutrivein
10.12 Pfizer, Inc.
10.13 Prestige Consumer Healthcare Inc.
10.14 Vitabiotics Ltd.
10.15 ZeaVision LLC
